drugset / Trial / NCT03620422

Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma

NCT03620422

RandomizedCrossoverQuadruple-blindOther

Summary

The study aim is to investigate if changes in osmolarity using mannitol challenge can evoke coughing reproducibly in mild allergic asthmatics compared with healthy controls and if salbutamol can affect this. Phase 1 of this study is a reproducibility analysis of cough dose response to mannitol in a cohort of mild allergic asthmatics and healthy controls. Phase 2 is a double-blind, placebo-controlled analysis in mild allergic asthmatics assessing the effects of salbutamol on mannitol induced cough.

Timeline

Start
2019-01-11
Primary completion
2020-01-31
Completion
2020-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salbutamol Unknown 5 mg/ml Inhaled

Indications